News
Medtronic Acquires SPR Therapeutics for $650 Million
The acquisition adds SPR’s FDA-cleared SPRINT PNS System, a short-term percutaneous peripheral nerve stimulation (PNS) therapy, to Medtronic’s pain therapy portfolio.
ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
The acquisition adds SPR’s FDA-cleared SPRINT PNS System, a short-term percutaneous peripheral nerve stimulation (PNS) therapy, to Medtronic’s pain therapy portfolio.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
